Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation

Links shared publicly online about this topic.

1,152
total visits

Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation

Results of two Phase II trials evaluating ALIMTA (pemetrexed for injection) in combination with a platinum chemotherapy and radiation for patients with locally advanced non-small cell lung cancer will be presented by Eli Lilly and Company at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Ill., on June 6, 2010.

View full resource at news-medical.net

Tags: Chemotherapy, Lung Cancer, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Medication, Lung, Pregnancy, Alimta, Eli Lilly and Company